Skip to main content

Table 3 Difference character between Km2-1 group And Km2-2 group

From: The machine learning methods to analyze the using strategy of antiplatelet drugs in ischaemic stroke patients with gastrointestinal haemorrhage

Variables

km2-1 group (N = 160)

km2-2 group (N = 108)

P*

Age, years

62.78(13.19)

73.26(11.38)

 < 0.001

Female, %

43(26.9)

65(60.2)

 < 0.001

Admission NIHSS score

10.22(6.50)

14.56(7.50)

 < 0.001

Statins In Hospital, %

158(98.7)

98(90.7)

 < 0.001

Diastolic Blood Pressure, mmHg

85.91(16.88)

79.58(15.42)

0.002

History of Smoking, %

80(50.0)

22(20.4)

 < 0.001

History of Drinking, %

43(26.9)

5(4.6)

 < 0.001

History of Stroke, %

8(5.0)

16(14.8)

0.006

History of Hypertension, %

66(41.3)

62(57.4)

0.009

History of Diabetes Mellitus, %

17(10.6)

25(23.1)

0.006

History of CHD, %

7(4.4)

26(24.1)

 < 0.001

History of Antiplatelet Drug, %

8 (5.0)

22(20.4)

 < 0.001

History of Antihypertensive, %

40(25.0)

58(53.7)

 < 0.001

History of Hypoglycaemic, %

10(6.2)

22(20.4)

0.003

Platelet, mmol/l

185.21(54.83)

168.35(63.67)

0.022

INR

0.96(0.08)

1.05(0.13)

 < 0.001

ALT, mmol/l

24.56(15.84)

20.44(11.80)

0.022

Triglyceride, mmol/l

1.97(1.67)

1.25(0.63)

 < 0.001

Total cholesterol, mmol/l

4.77(0.95)

3.74(0.84)

 < 0.001

LDL-C, mmol/l

2.93(0.80)

2.08(0.70)

 < 0.001

  1. P* was calculated by ANOVA, Chi-square test as appropriate. CHD Coronary Heart Disease, INR international normalized ratio, ALT glutamic-pyruvic transaminase, LDL-C low-density lipoprotein